Table 1 Reported antimalarial treatment practices of health care providers in six study sites of three states/regions, Myanmar (n = 32)
Health care | Treatment | Study region A | Study region B | Study region C | Total |
|---|---|---|---|---|---|
Confirmed uncomplicated falciparum malaria | |||||
Public sector (n = 24) | ACT + PQ (correct dose and course) | 6/6 (100%) | 10/10 (100%) | 8/8 (100%) | 24/24 (100%) |
Artesunate 2 tds × 3 days | 0 | 0 | 0 | 0 | |
Private sector (n = 8) | ACT + PQ (correct dose and course) | 1/2 (50%) | 1/2 (50%) | 3/4 (75%) | 5/8 (65%) |
Confirmed vivax malaria | |||||
Public sector (n = 24) | CQ + PQ (correct dose and course) | 8/8 (100%) | 5/5 (100%) | 11/11 (100%) | 24/24 (100%) |
CQ only | 0 | 0 | 0 | 0 | |
Private sector (n = 8) | CQ + PQ (correct dose and course) | 0/3 | 0/4 | 0/1 | 0/8 |
CQ only | 0 | 0 | 0 | 0 | |